Carol Lynch

Novartis wins European approval for biosimilar version of Roche`s MabThera

Novartis wins European approval for biosimilar version of Roche`s MabThera

Published 19/06/2017

Swiss drugmaker Novartis on Monday said it had won European approval for its biosimilar version of Roche's blockbuster Rituxan as the crosstown rivals go head-to-head on a drug to treat blood cancers and immunological diseases.

[more…]